Tech Company Financing Transactions
SynAgile Funding Round
SynAgile, based in Wilson, secured $10.4 million from TAMCAP and private investors.
Transaction Overview
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3465 N. Pines Way 104 PMB 218
Wilson, WY 83014
USA
Wilson, WY 83014
USA
Phone
Undisclosed
Website
Email Address
Overview
SynAgile is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to achieve stable plasma L-DOPA concentrations, and to provide convenient, noninvasive, continuous dopaminergic stimulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ephraim Heller
Chief Scientific Officer
Adam Heller
Vice President
Philip Plante
Vice President
John Spiridigliozzi
VP - Regulatory Affairs
Jennifer Harmon
VP - Regulatory Affairs
Taung Lau
Browse more venture capital transactions:
Prev: 8/25/2017: Romeo Power venture capital transaction
Next: 8/28/2017: Happify venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs